Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hextar Healthcare BhdXKLS:7803 +9.09% Debt-to-Equity is 0.01 as of Mar. 2026, which is 50% below its 10-year median of 0.02. The stock has 3 warning signs investors should review. Among 1,421 Chemicals companies, Hextar Healthcare Bhd ranks better than 99.93% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Hextar Healthcare Bhd's Debt-to-Equity or its related term are showing as below:
XKLS:7803'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0 Med: 0.02 Max: 0.35
Current: 0.01
During the past 13 years, the highest Debt-to-Equity Ratio of Hextar Healthcare Bhd was 0.35. The lowest was 0.00. And the median was 0.02.
XKLS:7803's Debt-to-Equity is ranked better than 99.93% of 1421
companies
in the Chemicals industry
Industry Median: 0.36
vs XKLS:7803: 0.01
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Hextar Healthcare Bhd Debt-to-Equity Related Terms
Hextar Healthcare Bhd Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Hextar Healthcare Bhd's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:7803 vs LIN, SHW, ECL: Debt-to-Equity Comparison
For the Specialty Chemicals subindustry, Hextar Healthcare Bhd's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hextar Healthcare Bhd Debt-to-Equity vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Hextar Healthcare Bhd's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Hextar Healthcare Bhd's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hextar Healthcare Bhd (XKLS:7803) has a Debt-to-Equity of 0.01 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Hextar Healthcare Bhd and its competitors. This is 50% below median its historical median of 0.02. According to the industry distribution chart, Hextar Healthcare Bhd ranks #1 out of 1421 companies in the Chemicals industry, placing it in the top 0.099999999999994%.
Is Hextar Healthcare Bhd's Debt-to-Equity too high?
Hextar Healthcare Bhd's current Debt-to-Equity of 0.01 is 50% below median its 10-year median of 0.02. The Chemicals industry median Debt-to-Equity is 0.36. Hextar Healthcare Bhd's value of 0.01 is 97.2% below this industry median. Based on the distribution chart, Hextar Healthcare Bhd ranks #1 out of 1421 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers.
How does Hextar Healthcare Bhd's Debt-to-Equity compare to LIN and SHW?
According to the Chemicals industry distribution chart, Hextar Healthcare Bhd ranks #1 out of 1421 companies for Debt-to-Equity. This places Hextar Healthcare Bhd in the top 0% of its industry — outperforming the majority of peers. The industry median Debt-to-Equity is 0.36. Hextar Healthcare Bhd's value of 0.01 is 97.2% below this benchmark. While the company's 10-year median is 0.02 vs. the industry median of 0.36, Hextar Healthcare Bhd has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Chemicals company?
The median Debt-to-Equity among Chemicals companies is 0.36, based on 1,421 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hextar Healthcare Bhd's current Debt-to-Equity of 0.01 is 97.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Hextar Healthcare Bhd and its competitors. For the Chemicals industry, the median Debt-to-Equity is 0.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hextar Healthcare Bhd's current Debt-to-Equity is 0.01, which is 50% below median its own 10-year median of 0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hextar Healthcare Bhd stock overvalued right now?
Based on GuruFocus' analysis, Hextar Healthcare Bhd (XKLS:7803) is currently considered Possible Value Trap. The stock's GF Value™ is RM0.15, compared to a current price of RM0.06 — trading 60% below its estimated fair value. The current Debt-to-Equity is 0.01, which is 50% below median its 10-year median of 0.02 and 97.2% below the Chemicals industry median of 0.36. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Hextar Healthcare Bhd (XKLS:7803), the current Debt-to-Equity is 0.01 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Hextar Healthcare Bhd is principally involved in investment holding. Through its subsidiaries, it manufactures and sells rubber gloves. The company offers a wide range of industrial and safety gloves, household rubber gloves, and disposable vinyl and nitrile gloves. The company operates in three segments: Gloves operation, Medical devices operation, and Investment holding. The company generates the majority of its revenue from the Gloves operation segment. It has operations in Europe, Asia, North and South America, and the Rest of the world.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7803 has been successfully added to your 
